tirzepatide for metabolic dysfunction In the SYNERGY-NASH trial, researchers assessed the efficacy and safety of once-weekly in persons with dysfunction–associated steatohepatitis (MASH) and moderate or severe fibrosis. Full trial results and Plain Language Summary tirzepatide liver Effect of Tirzepatide

If you are someone who relies on sparkling water for hydration, this adjustment might feel significant

Biogerontology 26 , 178

The FDA label notes that tirzepatide is not recommended for patients with severe gastrointestinal disease, including severe gastroparesis

Ro sells FDA-approved brand-name drugs: Wegovy, Zepbound, cash-pay Ozempic, and a new oral orforglipron option added in April 2026

This gives bacteria more time to break it down and can lead to gas and sulfur burps

These data may be suggestive of developments in pancreatic -cell function because increased circulating proinsulin/insulin ratios and proinsulin/C-peptide are important markers of initial and increasing pancreatic -cell secretory dysfunction